We use cookies to improve site performance and enhance your user experience. If you'd like to disable
cookies on this device, please see our
cookie management page.
If you close this message or continue to use this site, you consent
to our use of cookies on this devise in accordance with our
cookie policy, unless you disable
them.
REWARDS:
■ Historically low valuations
■ M&A activity
■ Significant growth potential
■ Posted absolute returns in 2008
RISKS:
■ High volatility
■ Threat of US healthcare reform
■ Currency risk from US holdings
subscriber-only content
visible-status-Subscription-Only story-url-FundTip_BiotechTrust_30June.xml
